Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about AIIMS Bhubaneshwar should focus on health research: Nadda
Union Health Minister J.P Nadda on Thursday said that the newly- inaugurated All India Institute of Medical Sciences (AIIMS) here should take steps towards research and explore new avenues of expanding tertiary healthcare delivery.
- Read more about FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
The U.S. Food and Drug Administration approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional kidney or lung abnormalities after they receive a stem cell transplant from blood or bone marrow called hematopoietic stem cell transplantation (HSCT). This is the first FDA-approved therapy for treatment of severe hepatic VOD, a rare and life-threatening liver condition. Defitelio is marketed by Jazz Pharmaceuticals based in Palo Alto, California.
- Read more about FDA allows use of investigational test to screen blood donations for Zika virus
The U.S. Food and Drug Administration today announced the availability of an investigational test to screen blood donations for Zika virus. The screening test may be used under an investigational new drug application (IND) for screening donated blood in areas with active mosquito-borne transmission of Zika virus. The test is manufactured by Roche Molecular Systems, Inc., based in Branchburg, New Jersey.

[adsense:336x280:8701650588]
- Read more about NATCO to sale US based pharmacy store
Natco Pharma decided to sales its US based pharmacy store. Natco decided in thier board meeting to sale of its Save Mart Store in the USA.
- Read more about NATCO Pharma notified on USFDA inspection
Natco Pharma Limited notified that an inspection was conducted by the United States Food & Drug Administration (USFDA) in two of its manufacturing facilities.
- Read more about U.S. FDA grants orphan drug designation to adaptimmune’s T-cell therapy targeting NY-ESO
Adaptimmune Therapeutics plc announced that the U.S. Food and Drug Administration (FDA)'s Office of Orphan Products Development has granted orphan drug designation for the company’s affinity enhanced T-cell therapy targeting NY-ESO for the treatment of soft tissue sarcoma, a solid tumor cancer.
- Read more about Diabetes drug increases risk of bladder cancer
A drug used in the treatment of diabetes can increase the risk of bladder cancer, warns a new study adding that the risk increases with the rising duration of use and the dose.
- Read more about Pharma Shifting Business Model to Meet Growing Multidrug Resistance
The rising cost of raw materials, stringent regulatory requirements and increasingly competitive environment all are rapidly eroding the profit margins of many antibiotic manufacturers. BCC Research reveals in its new report that these challenges, and the growing problem of antibiotic resistance, have dramatically shifted the business models of some of the industry’s leading pharmaceutical companies.
- Read more about Ultra sensitive biosensor could revolutionise cancer diagnosis
Opening the door for new detection method that could allow doctors to diagnose patients with certain cancers far earlier than possible today, researchers have developed an optical sensor that they claim is one million times more sensitive than the current best available.
- Read more about Universal flu vaccine comes a step closer
In a major advance towards a universal flu jab which would protect people against all strains of the virus, researchers have developed a new vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.